A gain-of-function mutant p53-HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress

被引:75
作者
Li, D. [1 ]
Yallowitz, A. [1 ]
Ozog, L. [1 ]
Marchenko, N. [1 ]
机构
[1] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA
关键词
mutant p53; HSF1; Ser326; ErbB2; EGFR; Hsp90; HEAT-SHOCK FACTOR-1; MOLECULAR CHAPERONE INHIBITORS; TRANSCRIPTION FACTOR HSF1; LI-FRAUMENI-SYNDROME; BREAST-CANCER; POOR-PROGNOSIS; P53; GAIN; HSP90; CARCINOGENESIS; TUMORS;
D O I
10.1038/cddis.2014.158
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To overcome proteotoxic stress inherent to malignant transformation, cancer cells induce a range of adaptive mechanisms, with the master transcription factor heat-shock factor 1 (HSF1)-orchestrated response taking center stage. Here we define a novel gain-of-function of mutant p53 (mutp53), whereby mutp53-overexpressing cancer cells acquire superior tolerance to proteotoxic stress. mutp53 via constitutive stimulation of EGFR and ErbB2 signaling hyperactivates the MAPK and PI3K cascades, which induce stabilization and phosphoactivation of HSF1 on Ser326. Moreover, mutp53 protein via direct interaction with activated p-Ser326 HSF1 facilitates HSF1 recruitment to its specific DNA-binding elements and stimulates transcription of heat-shock proteins including Hsp90. In turn, induced Hsp90 stabilizes its oncogenic clients including EGFR, ErbB2 and mutp53, thereby further reinforcing oncogenic signaling. Thus, mutp53 initiates a feed forward loop that renders cancer cells more resistant to adverse conditions, providing a strong survival advantage.
引用
收藏
页码:e1194 / e1194
页数:11
相关论文
共 37 条
[1]   Oxidative Stress Impairs the Heat Stress Response and Delays Unfolded Protein Recovery [J].
Adachi, Masaaki ;
Liu, Yaohua ;
Fujii, Kyoko ;
Calderwood, Stuart K. ;
Nakai, Akira ;
Imai, Kohzoh ;
Shinomura, Yasuhisa .
PLOS ONE, 2009, 4 (11) :A57-A66
[2]   Wild-type EGFR Is Stabilized by Direct Interaction with HSP90 in Cancer Cells and Tumors [J].
Ahsan, Aarif ;
Ramanand, Susmita G. ;
Whitehead, Christopher ;
Hiniker, Susan M. ;
Rehemtulla, Alnawaz ;
Pratt, William B. ;
Jolly, Shruti ;
Gouveia, Christopher ;
Kristy Truong ;
Van Waes, Carter ;
Ray, Dipankar ;
Lawrence, Theodore S. ;
Nyati, Mukesh K. .
NEOPLASIA, 2012, 14 (08) :670-+
[3]   Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[4]   Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update [J].
Ciocca, Daniel R. ;
Arrigo, Andre Patrick ;
Calderwood, Stuart K. .
ARCHIVES OF TOXICOLOGY, 2013, 87 (01) :19-48
[5]   Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis [J].
Dai, Chengkai ;
Whitesell, Luke ;
Rogers, Arlin B. ;
Lindquist, Susan .
CELL, 2007, 130 (06) :1005-1018
[6]   Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis [J].
Dai, Chengkai ;
Santagata, Sandro ;
Tang, Zijian ;
Shi, Jiayuan ;
Cao, Junxia ;
Kwon, Hyoungtae ;
Bronson, Roderick T. ;
Whitesell, Luke ;
Lindquist, Susan .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10) :3742-3754
[7]   Identification of novel functional TBP-binding sites and general factor repertoires [J].
Denissov, Sergey ;
van Driel, Marc ;
Voit, Renate ;
Hekkelman, Maarten ;
Hulsen, Tim ;
Hernandez, Nouria ;
Grummt, Ingrid ;
Wehrens, Ron ;
Stunnenberg, Hendrik .
EMBO JOURNAL, 2007, 26 (04) :944-954
[8]   Mutant p53: one name, many proteins [J].
Freed-Pastor, William A. ;
Prives, Carol .
GENES & DEVELOPMENT, 2012, 26 (12) :1268-1286
[9]   Exploring the specificity of the PI3K family inhibitor LY294002 [J].
Gharbi, Severine I. ;
Zvelebil, Marketa J. ;
Shuttleworth, Stephen J. ;
Hancox, Tim ;
Saghir, Nahid ;
Timms, John F. ;
Waterfield, Michael D. .
BIOCHEMICAL JOURNAL, 2007, 404 :15-21
[10]   Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety [J].
Guo, Feng ;
Letrent, Stephen P. ;
Munster, Pamela N. ;
Britten, Carolyn D. ;
Gelmon, Karen ;
Tolcher, Anthony W. ;
Sharma, Amarnath .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) :97-109